Upload Image (Max 20MB per Image)
CSL Behring has obtained expanded label approval for a C1-esterase inhibitor (C1-INH) concentrate, Berinert, for short-term prophylaxis in adults and children with hereditary angioedema (HAE) in 23 European countries. Berinert is ...
Tags: CSL Behring, Expanded Label Approval